title: Dendrimer grafts for delivery of 5-fluorouracil.
abstract: Polyamidoamine (PAMAM) dendrimers were prepared by linking methyl methacrylate and ethylenediamine successively on an amine core. Surface modification of PAMAM dendrimer was done by fatty acid grafting converting them to a unimolecular micellar system (Dendrimer grafts). IR, 1H NMR, 13C NMR studies confirmed the structure. The drug 5-fluorouracil (5-FU) was entrapped in dendrimer grafts. The effects of various solvents (ethanol, dichloromethane, tetrahydrofuran), pH and ionic strength on solubilization of 5-FU were determined. Phospholipid was further coated on the dendrimer grafts. The product was lyophilized and obtained as yellowish-white powder. Average particle size was ca. 375 nm as determined by Malvern's Mastersizer 4. Drug loading was ca. 53% by weight. Stability studies were conducted for 1 month at room temperature and 40 degrees C, where the systems were relatively stable. Release rate was sustained across cellulose tubing in PBS. In vivo studies were performed in albino rats and pharmacokinetic parameters and bioavailability were determined from the plasma profile of 5-FU. The phospholipid coated dendrimer graft formulation was found to be more effective orally than free drug. The lymphatic uptake was also increased indicating absorption of the developed formulation through the lymphatic route.
authors: Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar, India.
authors: P K
authors: PK
authors: Tripathi
authors: A J
authors: AJ
authors: Khopade
authors: S
authors: S
authors: Nagaich
authors: S
authors: S
authors: Shrivastava
authors: S
authors: S
authors: Jain
authors: N K
authors: NK
authors: Jain
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001682:Biological Availability; D050091:Dendrimers; D005029:Ethylenediamines / Q000737:chemistry; D005227:Fatty Acids / Q000737:chemistry; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005612:Freeze Drying; D007275:Injections, Intravenous; D008196:Lymph / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008567:Membranes, Artificial; D008689:Methacrylates; D008823:Micelles; D010316:Particle Size; D010743:Phospholipids / Q000737:chemistry; D011073:Polyamines; D051381:Rats; D017207:Rats, Sprague-Dawley; D012997:Solvents; D013055:Spectrophotometry, Infrared
chemical_list: D000964:Antimetabolites, Antineoplastic; D050091:Dendrimers; D005029:Ethylenediamines; D005227:Fatty Acids; D008567:Membranes, Artificial; D008689:Methacrylates; D008823:Micelles; C104700:PAMAM Starburst; D010743:Phospholipids; D011073:Polyamines; D012997:Solvents; D005472:Fluorouracil